Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan in Fibromyalgia
NCT03538054Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Dextromethorphan with Placebo (2 arms). Primary endpoint: Daily Self-reported Pain Severity at 4 weeks. Started Jun 2018; status: completed.
02
Drugs
dextromethorphan
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT03538054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03538054.